Critical Contrast: Hims & Hers Health (NYSE:HIMS) & United Treatment Centers (OTCMKTS:POTN)

Hims & Hers Health (NYSE:HIMSGet Free Report) and United Treatment Centers (OTCMKTS:POTNGet Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation.

Analyst Ratings

This is a summary of recent recommendations for Hims & Hers Health and United Treatment Centers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health 3 10 2 0 1.93
United Treatment Centers 0 0 0 0 0.00

Hims & Hers Health currently has a consensus target price of $38.92, suggesting a potential downside of 21.22%. Given United Treatment Centers’ higher possible upside, analysts plainly believe United Treatment Centers is more favorable than Hims & Hers Health.

Profitability

This table compares Hims & Hers Health and United Treatment Centers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Hims & Hers Health 9.63% 26.26% 13.06%
United Treatment Centers N/A N/A N/A

Earnings and Valuation

This table compares Hims & Hers Health and United Treatment Centers”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Hims & Hers Health $1.48 billion 7.56 $126.04 million $0.80 61.75
United Treatment Centers N/A N/A N/A N/A N/A

Hims & Hers Health has higher revenue and earnings than United Treatment Centers.

Insider and Institutional Ownership

63.5% of Hims & Hers Health shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by insiders. Comparatively, 0.2% of United Treatment Centers shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Hims & Hers Health beats United Treatment Centers on 8 of the 9 factors compared between the two stocks.

About Hims & Hers Health

(Get Free Report)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

About United Treatment Centers

(Get Free Report)

Diamond Wellness Holdings Inc., through its subsidiaries, engages in the development and sale of hemp-derived cannabidiol (CBD) oil products. It offers flavored and unflavored oils; vaping pens and additives; edibles, such as chewable gummies and lollipops; capsules; beverage energy/relaxation shots; topical application creams in various concentrations; dog and cat wellness products in various dosages and delivery formats; skin care, bath, and body products; and hemp flowers. The company provides its products under various brands, including Diamond CBD, Chill, Relax, MediPets, and Meds BioTech, as well as various other brands. It sells its products through distributors and resellers, as well as through its Website. The company was formerly known as PotNetwork Holdings, Inc. Diamond Wellness Holdings Inc. is based in Fort Lauderdale, Florida.

Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.